News Lilly reveals $3bn orforglipron facility in Netherlands After so many announcements of new facility builds in the US, Eli Lilly has made a welcome commitment to a European investment.
News Lilly climbs on stellar GLP-1 drug sales gain Eli Lilly is celebrating a massive 54% increase in its third-quarter revenues to $17.6 billion, driven by its medicines for diabetes and obesity.
News FDA hands out first national priority vouchers to nine firms The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher programme.
News UK's VR-powered medicine maker scheme delivers first results A UK initiative to train a new generation of workers in medicines manufacturing has been taken up by around 1,200 people since it started last year.
News AZ starts work on Virginia plant in $50bn US investment plan The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ground on a facility in Virginia.
News FDA pilots fast-track scheme for US-made generics In another effort to boost domestic drug manufacturing, the FDA is piloting fast-track reviews for generics tested and made in US facilities.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
